Prostate cancer: PARP inhibitors in prostate cancer

December 06, 2023 • 00:26:43
Prostate cancer: PARP inhibitors in prostate cancer
COR2ED - Oncology Medical Conversation
Prostate cancer: PARP inhibitors in prostate cancer

Dec 06 2023 | 00:26:43

/

Show Notes

COR2ED Medical Education: Dr Jason Alcorn, nurse consultant for Uro-Oncology & Andrology at the Mid Yorkshire Hospitals NHS Trust, United Kingdom and Dr Alicia Morgans, Genitourinary Medical Oncologist and Medical Director of the Survivorship Program at the Dana-Farber Cancer Institute in the United States, discuss 'PARP inhibitors in prostate cancer: Management of adverse events and the importance of communication with patients’ as part of the GU NURSES CONNECT podcast series covering ‘PARP inhibitors in prostate cancer’.

In this podcast, the experts discuss adverse events associated with PARP inhibitors and the management of them, in particular thrombocytopenia, gastrointestinal effects and fatigue. Jason provides some insight into how nurses support and communicate with patients, the importance of early reporting of side effects and how to manage these. Finally, the ongoing trials of PARP inhibitors in combination with other prostate cancer treatments are also considered and what these trials may mean for patients.

Other Episodes

Episode

December 06, 2023 • 00:23:12
Episode Cover

Breast cancer: Oral SERDs in ER+ BC. Part 1 - Efficacy, safety and the treatment landscape

In this podcast, the experts give an overview of  the EMERALD trial  and present elacestrant as the first, and currently only, oral SERD to...

Listen

Episode

March 21, 2025 • 00:26:05
Episode Cover

Best practices in molecular testing and targeted therapy for HR+/HER2- metastatic breast cancer

This podcast explores the best practices in molecular testing and targeted therapy for HR+/HER2- metastatic breast cancer.   Dr Rena Callahan and Dr Roberto Salgado...

Listen

Episode

May 15, 2024 • 00:25:30
Episode Cover

Understanding the needs of different patient populations in colorectal cancer

Do you understand the needs of different patient groups with colorectal cancer?  Do you know about the barriers to treatment experienced by different ethnicities,...

Listen